AmbioPharm is a full-service peptide Contract Development & Manufacturing Organization (CDMO) developing manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In manufacturing facilities in their South Carolina, USA Headquarters, and in Shanghai, China, they manufacture New Chemical Entities (NCEs) APIs under cGMP for clients worldwide.
